
================================================================================

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 ---------------

                                    FORM 8-K

                                 CURRENT REPORT


                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                Date of Report (Date of earliest event reported)
                      December 22, 2004 (December 16, 2004)



                                 GENE LOGIC INC.
             (Exact name of registrant as specified in its charter)



        DELAWARE                   0-23317                 06-1411336
- ------------------------   -------------------------   -----------------------
(State of Incorporation)    (Commission File Number)        (IRS Employer
                                                        Identification Number)



                             610 Professional Drive
                          Gaithersburg, Maryland 20879
                    (Address of principal executive offices)


                                 (301) 987-1700
              (Registrant's telephone number, including area code)


                                       NA
          (Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

================================================================================


<PAGE>


SECTION 1.  REGISTRANT'S BUSINESS AND OPERATIONS

Item 1.01.        Entry Into a Definitive Material Agreement

         The Company's Board of Directors has approved certain increases in
non-employee Director compensation, effective January 1, 2005. In addition, in
connection with the establishment of a non-executive Chairman position, the
Board of Directors recently established compensation for the position and for
the current Chairman, effective November 9, 2004, the date of his election to
office.

         The attached Exhibit 10.6a, incorporated herein by reference, sets
forth the new compensation.



Item 9.01.        Financial Statements and Exhibits

(c)          Exhibits

Exhibit Number                          Description
- --------------                  ----------------------------------------------
    10.6a                       Summary of Non-Employee Director Compensation.


<PAGE>




                                    SIGNATURE

         Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                            Gene Logic Inc.


                                            By: /s/ Philip L. Rohrer, Jr.
                                            --------------------------
                                            Philip L. Rohrer, Jr.
                                            Chief Financial Officer



Dated:  December 22, 2004




<PAGE>



                                  EXHIBIT INDEX


Exhibit Number                              Description
- --------------                              -----------
10.6a                                       Summary of Non-Employee Director
                                            Compensation.

